pifithrin has been researched along with Angiogenesis, Pathologic in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dabrowska-Iwanicka, A | 1 |
| Olszewska, D | 1 |
| Jalili, A | 1 |
| Makowski, M | 1 |
| Grzela, T | 1 |
| Marczak, M | 1 |
| Hoser, G | 1 |
| Giermasz, A | 1 |
| Golab, J | 1 |
| Jakóbisiak, M | 1 |
1 other study available for pifithrin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Augmented antitumour effects of combination therapy with TNP-470 and chemoimmunotherapy in mice.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Benzothiazoles; Blotting, Western; Cell Div | 2002 |